Cargando…
Reprogramming of Mice Primary Hepatocytes into Insulin-Producing Cells by Transfection with Multicistronic Vectors
The neogenesis of insulin-producing cells (IPCs) from non-beta-cells has emerged as a potential method for treating diabetes mellitus (DM). Many groups have documented that activation of pancreatic transcription factor(s) in hepatocytes can improve the hyperglycemia in diabetic mice. In the present...
Autores principales: | Luo, Haizhao, Chen, Rongping, Yang, Rui, Liu, Yan, Chen, Youping, Shu, Yi, Chen, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070478/ https://www.ncbi.nlm.nih.gov/pubmed/25006589 http://dx.doi.org/10.1155/2014/716163 |
Ejemplares similares
-
Generation of stable Drosophila cell lines using multicistronic vectors
por: González, Monika, et al.
Publicado: (2011) -
Validation of CRISPR activation system in Aedes cells using multicistronic plasmid vectors
por: Jaiswal, Vijeta, et al.
Publicado: (2023) -
Patient-Specific Therapy via Cell-Reprogramming Technology: a Curative Potential for Patients with Diabetes
por: Luo, Haizhao, et al.
Publicado: (2015) -
Regulated multicistronic expression technology for mammalian metabolic engineering
por: Fussenegger, Martin, et al.
Publicado: (1998) -
Production and Application of Multicistronic Constructs for Various Human Disease Therapies
por: Shaimardanova, Alisa A., et al.
Publicado: (2019)